top of page

Eyes on Pharma
Check-out What Intel Caught our Eye

Jana Chisholm
Jan 317 min read
JP Morgan Healthcare Conference Key Takes, and More
We've had Eye's On the JP Morgan Healthcare Conference, Lifesciences 2024 restructuring stats, and some new drug development partnerships.

Robin Bateman
Jan 27 min read
2024 FDA Approvals
Check out the final listings of FDA NDA and BLA approvals for 2024.

Jana Chisholm
Dec 11, 202416 min read
Eyes on 3Q24 Financial Results
We've highlighted a few firms: Lilly, AbbVie, Pfizer, Novo Nordisk, BMS, Roche, Novartis, Merck, AstraZeneca, GSK, Viatris, Teva, and Amgen.

Jana Chisholm
Oct 5, 20246 min read
Eyes on BMS, Pfizer, & Amgen
Eye's on the Amgen data releases for gMG & Atopic Dermatitis, the BMS approval of Cobenfy for schizophrenia, and Pfizer's Oxbryta recall...

Jana Chisholm
Jun 18, 20243 min read
Eyes on ASCO 2024
The ASCO 2024 annual meeting took place from 31st May to 4th June. A number of firms presented data, and others used this as an opportunity

jroele
Jun 7, 20242 min read
Our Comments & Links on Top 4 Biggest Drugs in 2023
Check out this Top Drugs of 2023 list with links to interesting reports in PharmaTell Studio. Contact us for a trial.


Jana Chisholm
Jun 5, 20244 min read
Eyes on Recent News from BioPharma + a 2023 Top WW 2023 List
This week we've had eyes on BioPharma happenings plus a 2023 Top Selling Drugs list.

Jana Chisholm
May 18, 20245 min read
Eyes on Pharma Restructures + Pfizer's Clinical SAE
We've had Eyes On recent news further clarifying company restructures. In the midst of refining pipelines, and cutting corporate spending ..

Jana Chisholm
Mar 24, 20244 min read
Eyes on Current Events - Deals, Approvals & Operations
We've been trying to keep up with current events - here's some of what we've hay Eyes On this week.

Jana Chisholm
Jan 10, 20247 min read
Eyes on Genetic Medicines & Pipelines
Following up on our previous post about Gene Therapies, we are sharing data on Genetic Medicines in development - pipelines, targets, dates

Jana Chisholm
Jan 2, 20247 min read
Eyes on Gene Therapy - The Background
We've been keeping Eyes On the Gene Therapy area - and thought we would post some general information about the area ...


Jana Chisholm
Dec 1, 20233 min read
Eyes on Clinical Trial Data, Supply Upgrades, and Patent Litigation
The news this week was full of "Ups-n-Downs." We've noted a few here and know there were more surprises with clinical data results, M&A, and

Jana Chisholm
Nov 24, 20233 min read
Eyes on Casgevy, Pfizer & More
Some of this week's news includes Casgevy Approval, Novo's REDEFINE 4 Trial, , new Manufacturing plant and more.


Robin Bateman
Oct 26, 20236 min read
Eyes on Obesity & Weight Loss
We found ourselves looking closer at the disease, the history of weight loss medications, and the potential impact of effective weight manag


Robin Bateman
Feb 27, 20222 min read
Opioids, SPACs, Top 10 Lists, and more Results
Check out the latest on some of the Opioid Litigation, SPACS, and yes two Top 10 Lists!


Robin Bateman
Feb 22, 20222 min read
R&D Trends, ASCO-GU, & Earnings
The Eyes on Pharma team was caught up in reviewing global R&D trends and following the updates from ASCO-GU ...
bottom of page